Timothy P. Kelly - Mar 1, 2021 Form 4/A - Amendment Insider Report for Homology Medicines, Inc. (FIXX)

Role: Officer
Signature: /s/ Bradford Smith, Attorney-in-Fact for Timothy P. Kelly
Stock symbol: FIXX
Transactions as of: Mar 1, 2021
Transactions value $: -$69,563
Form type: 4/A - Amendment
Date filed: 9/8/2021, 04:05 PM
Date Of Original Report: Mar 3, 2021
Next filing: Sep 8, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FIXX	Common Stock	Sale	-$69.6K	-6.23K	-100%	$11.16^*	0	Mar 1, 2021	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F2	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.
F3	The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

Chief Technical Operations Officer The purpose of this Form 4 Amendment is to correct the original Form 4 filed on March 3, 2021. The original Form 4 erroneously used Transaction Code "A" instead of "D" in Column 4 of Table I.